Based on the minimal information, the pipeline device performed as intended; as indicated by successful deployment of the device.No device issue was reported during the procedure.Hemorrhage (rupture of the aneurysm) is a known inherent risk of endovascular procedure and is documented in the pipeline instruction for use (ifu).Delayed aneurysm rupture after flow diversion occurs in approximately 1% of patients, and its mechanism may involve sudden hemodynamic changes in intra-aneurysmal flow pattern or aneurysm wall weakening due to inflammation and proteolytic enzymes within the developing red thrombus.The cause of the hemorrhage (aneurysm rupture) cannot be reliably determined; however, per the reported information, review of ifu, and review of literature to investigate the complaint, the most likely cause for the complaint is patient condition.All devices are 100% tested and all products are 100% inspected for damages and irregularities during manufacture.If information is provided in the future, a supplemental report will be issued.
|